-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|October 25, 2024

Collaborating for Better Care: Healthcare Providers and Payers in Lupus Nephritis

Author(s)Ryan Haumschild, PharmD, MS, MBA, Jorge Larranaga, MD, Jeremy Wigginton, MD

Key Takeaways

Panelists discuss how health care providers and payers can collaborate more effectively to optimize lupus nephritis care.

Episodes in this series

EP. 1 Understanding the Clinical Burden and Prevalence of Lupus Nephritis

EP. 1 Understanding the Clinical Burden and Prevalence of Lupus Nephritis

EP. 2 Cost Drivers in Lupus Nephritis

EP. 2 Cost Drivers in Lupus Nephritis

EP. 3 Urgency to Treat in Lupus Nephritis: Goals of Therapy and Early Diagnosis Strategies

EP. 3 Urgency to Treat in Lupus Nephritis: Goals of Therapy and Early Diagnosis Strategies

EP. 4 Guideline Updates in Lupus Nephritis: Impacts on Clinical Decision-Making

EP. 4 Guideline Updates in Lupus Nephritis: Impacts on Clinical Decision-Making

EP. 5 Tailoring Lupus Nephritis Treatment: Key Considerations and Specialist Approaches

EP. 5 Tailoring Lupus Nephritis Treatment: Key Considerations and Specialist Approaches

EP. 6 Belimumab and Voclosporin: Clinical Insights and Payer Evaluations in Lupus Nephritis

EP. 6 Belimumab and Voclosporin: Clinical Insights and Payer Evaluations in Lupus Nephritis

EP. 7 Improving Access to Lupus Nephritis Treatment: Strategies and Resources

EP. 7 Improving Access to Lupus Nephritis Treatment: Strategies and Resources

EP. 8 Lupus Nephritis Management: Monitoring Strategies and Long-Term Study Results

EP. 8 Lupus Nephritis Management: Monitoring Strategies and Long-Term Study Results

EP. 9 Collaborating for Better Care: Healthcare Providers and Payers in Lupus Nephritis

EP. 9 Collaborating for Better Care: Healthcare Providers and Payers in Lupus Nephritis

1 KOL is featured in this series.

EP. 10 From Guidelines to Practice: Advancing Lupus Nephritis Treatment

1 KOL is featured in this series.

EP. 11 Looking Ahead: Anticipating Changes in Lupus Guidelines and Clinical Practice

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Experts featured in this series.

The Right Fit First: How Psychiatrists Approach Initial Treatment and Patient Adherence

ByPatrick Runnels, MD, MBA,Ginger Shupe, MD,Gus Alva, MD, DFAPA,Joe Goldberg, MD

Published: June 23rd 2026 | Updated: June 16th 2026

Experts featured in this series.

Formulary Frustrations: How Insurance Constraints Shape Psychiatric Treatment Decisions

ByPatrick Runnels, MD, MBA,Ginger Shupe, MD,Gus Alva, MD, DFAPA,Joe Goldberg, MD

Published: June 23rd 2026 | Updated: June 16th 2026

Navigating the Human Side of Extrapulmonary Neuroendocrine Carcinoma: Patient Burden and Caregiver Support

ByRyan Haumschild, PharmD, MBA,William K. Oh, MD,Aman Chauhan, MD,Namrata Vijayvergia, MD,Sandy Kotiah, MD

June 22nd 2026

The 5-Year Horizon: Evolving Paradigms in Ischemic Stroke Management

ByMark Makhinson, PharmD, MBA,Andrew Russman, DO, FAHA, FAAN,Danison Emmerson, MD,David Z. Rose, MD

June 22nd 2026

Closing the Gap: Underrecognition and the Critical Need for Early Diagnosis in Extrapulmonary Neuroendocrine Carcinoma

ByRyan Haumschild, PharmD, MBA,William K. Oh, MD,Aman Chauhan, MD,Namrata Vijayvergia, MD,Sandy Kotiah, MD

June 22nd 2026

Trending on AJMC

CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes

ATTR-CM Incidence, Prevalence Rose Sharply in the US

FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Zanubrutinib Tops Rivals in Real-World CLL Survival Study